Atossa Therapeutics Inc. (NASDAQ:ATOS) went down by -3.25% from its latest closing price compared to the recent 1-year high of $9.80. The company’s stock price has collected -4.49% of loss in the last five trading sessions. Press Release reported on 12/22/21 that Atossa Therapeutics Begins Enrollment of Phase 2 Clinical Study of Oral Endoxifen in Sweden
Is It Worth Investing in Atossa Therapeutics Inc. (NASDAQ :ATOS) Right Now?
Plus, the 36-month beta value for ATOS is at 1.98. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Atossa Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $8.75, which is $6.39 above the current price. ATOS currently public float of 126.57M and currently shorts hold a 13.66% ratio of that float. Today, the average trading volume of ATOS was 3.27M shares.
ATOS’s Market Performance
ATOS stocks went down by -4.49% for the week, with a monthly drop of -24.37% and a quarterly performance of -51.15%, while its annual performance rate touched 26.27%. The volatility ratio for the week stands at 6.41% while the volatility levels for the past 30 days are set at 6.85% for Atossa Therapeutics Inc.. The simple moving average for the period of the last 20 days is -13.52% for ATOS stocks with a simple moving average of -53.58% for the last 200 days.
Analysts’ Opinion of ATOS
Many brokerage firms have already submitted their reports for ATOS stocks, with Maxim Group repeating the rating for ATOS by listing it as a “Buy.” The predicted price for ATOS in the upcoming period, according to Maxim Group is $2 based on the research report published on January 26th of the previous year 2018.
ATOS Trading at -29.64% from the 50-Day Moving Average
After a stumble in the market that brought ATOS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.80% of loss for the given period.
Volatility was left at 6.85%, however, over the last 30 days, the volatility rate increased by 6.41%, as shares sank -21.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.98% lower at present.
During the last 5 trading sessions, ATOS fell by -4.49%, which changed the moving average for the period of 200-days by -27.32% in comparison to the 20-day moving average, which settled at $1.7020. In addition, Atossa Therapeutics Inc. saw -6.88% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ATOS starting from WEAVER GREGORY L, who sale 107,497 shares at the price of $5.58 back on Jul 02. After this action, WEAVER GREGORY L now owns 0 shares of Atossa Therapeutics Inc., valued at $599,833 using the latest closing price.
Stock Fundamentals for ATOS
The total capital return value is set at -72.33, while invested capital returns managed to touch -88.40. Equity return is now at value -24.70, with -23.50 for asset returns.
Based on Atossa Therapeutics Inc. (ATOS), the company’s capital structure generated 0.07 points at debt to equity in total, while total debt to capital is 0.07.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.73.